
Jan 15 (Reuters) - Hoth Therapeutics Inc HOTH.O:
HOTH THERAPEUTICS REACHES KEY EU REGULATORY INFLECTION POINT ADVANCING HT-001 ONCOLOGY TRIAL TOWARD MULTI-COUNTRY SITE ACTIVATION
HOTH THERAPEUTICS : COUNTRY-SPECIFIC PART II REGULATORY DECISIONS IN HUNGARY, SPAIN, & POLAND ARE EXPECTED BY JAN 19, 2026